The use of interferon- and RBV-free regimens for HCV is associated with better patients' experience and work productivity during treatment.
No takes yet. Share an insight, caveat, or question.
Younossi et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: